XiFin CEO Lâle White to Discuss Systemic Change Needed in the Shifting Diagnostics Market at the CCLA Annual Conference

Newly published paper to be unveiled at California Clinical Laboratory Association (CCLA) Annual Conference, details three key forces attacking industry’s ability to innovate and strategies that can help overcome impediments.

As the healthcare landscape continues to shift, payor dynamics play a crucial role in determining access to care and reimbursement for services. Recent data sheds light on the growing impact of Medicare Advantage plans and the increasing scrutiny surrounding prior authorizations, raising concerns about patient care delays and reimbursement rates for providers.

Lâle White, CEO and Executive Chairman at XiFin will address these critical issues during her presentation at the California Clinical Laboratory Association (CCLA) Annual Conference on October 24, 2024, at the Hilton Orange County, Costa Mesa. Lâle will delve into XiFin’s payor insight, with a special focus on the challenges and opportunities arising from Medicare and Medicare Advantage, and the pressing issue of prior authorization denials.

With Medicare Advantage enrollment now surpassing traditional Medicare, and denial rates higher under Medicare Advantage, coupled with ongoing regulatory changes, understanding and navigating the payor landscape is critical for providers seeking to maintain operational resilience while ensuring patients receive timely, necessary care. Lâle’s presentation will provide insights into how healthcare providers can adapt and thrive in this shifting environment.

In addition to her presentation, Lâle will unveil her newly published white paper, “Overcoming Impediments to Healthcare Innovation Requires Systemic Change,” at the conference. This white paper provides an in-depth analysis of three critical forces hindering healthcare innovation—rising costs, regulatory burdens, and complex payor structures. It outlines actionable strategies that healthcare providers can adopt to overcome these challenges and drive future success, including:

• How increasing costs and reimbursement challenges are impacting healthcare’s bottom line
• The influence of regulations and payor policies on healthcare innovation
• Strategies providers can implement to mitigate these forces and drive future success

Session Title: Fostering Resilience and Seizing Opportunities in Diagnostics Amidst a Shifting Market and Regulatory Landscape

Key Session Topics:

• Denial Rates Surge for Procedures Requiring Prior Authorizations: The 2024 data indicates a sharp increase in denials, with UnitedHealthcare and Blue Cross & Blue Shield showing some of the highest prior authorization denial rates
• Payor Policy Impacts Providers: Providers face substantial reimbursement challenges, with payors consistently denying claims and providers failing to appeal denied claims; even those successfully appealed payment delays
• The Innovation Paradigm: Innovation, a cornerstone of diagnostics, is under attack due to rising costs, shrinking reimbursements, and increased regulatory and payor pressures, but AI has the potential to be the great equalizer in battling these challenges

When: October 24, 2024, 2:00 pm PT

Where: Hilton Orange County, 3050 Bristol Street, Costa Mesa, CA

Interviews available upon request.